Renaissance Technologies - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 124 filers reported holding ACHILLION PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2019$25,517,000
+84.0%
4,231,600
+9.8%
0.02%
+66.7%
Q3 2019$13,869,000
+72.1%
3,852,600
+28.1%
0.01%
+71.4%
Q2 2019$8,059,000
+19.5%
3,007,000
+31.9%
0.01%
+16.7%
Q1 2019$6,746,000
+355.2%
2,279,000
+144.6%
0.01%
+200.0%
Q4 2018$1,482,000
+227.9%
931,800
+659.4%
0.00%
Q3 2018$452,000
-91.5%
122,700
-92.4%
0.00%
-100.0%
Q2 2018$5,324,000
+63.8%
1,608,819
+83.7%
0.00%
-25.0%
Q1 2018$3,250,000
-48.3%
875,899
-59.9%
0.00%
-42.9%
Q4 2017$6,286,000
+46.8%
2,182,467
+128.8%
0.01%
+40.0%
Q3 2017$4,283,000
+45.5%
953,975
+48.8%
0.01%
+25.0%
Q2 2017$2,944,000
-14.7%
641,300
-21.8%
0.00%
-20.0%
Q1 2017$3,452,000
-11.6%
819,900
-13.3%
0.01%
-16.7%
Q4 2016$3,904,000
-12.8%
945,189
+71.0%
0.01%
-25.0%
Q3 2016$4,476,000
+272.4%
552,600
+396.1%
0.01%
+166.7%
Q4 2015$1,202,000
-86.6%
111,400
-87.6%
0.00%
-88.0%
Q3 2014$8,955,000897,3000.02%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q2 2018
NameSharesValueWeighting ↓
RA Capital Management 12,033,220$92,896,00011.87%
RTW INVESTMENTS, LP 2,558,859$19,754,0007.17%
TURNER INVESTMENTS LLC 859,560$6,636,0001.80%
DAFNA Capital Management LLC 236,500$1,826,0001.58%
Ghost Tree Capital, LLC 250,000$1,930,0001.09%
Orbimed Advisors 11,519,700$88,932,0000.94%
Rock Springs Capital Management LP 1,220,000$9,418,0000.79%
Opus Point Partners Management, LLC 99,000$764,0000.59%
Bellevue Group AG 420,000$3,242,0000.59%
Cormorant Asset Management, LP 500,000$3,860,0000.58%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders